Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody)
2020-04-23 08:00
Samsung Biologics Earnings to Beat Consensus Again, Continues to Sign New Projects with Enhanced Virtual Support
2020-04-22 19:00
Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001
2020-04-20 23:00
Innovent Biologics Announces FDA Approval of Pemazyre™ (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma
2020-04-20 08:00
Nucleus Network's 10 Step Guide to conducting Clinical Trials during a time of uncertainty
2020-04-14 21:17
WuXi Biologics (Suzhou) Successfully Passed First EMA GMP Inspection
2020-04-14 08:00
Gracell to Present the First-in-human, Universal TruUCAR™ GC027 Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia at the AACR Annual Meeting
2020-04-13 21:00
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment
2020-04-10 11:39
Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis
2020-04-09 15:14
Samsung Biologics named Champion in 2020 CMO Leadership Awards
2020-04-08 20:00
THE.WAVE.TALK raises US$2M
2020-04-07 20:30
Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment
2020-04-06 08:00
Gracell Announces China NMPA Acceptance of Investigational New Drug Application for GC007g Cell Therapy for CD19 Positive Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
2020-04-03 22:00
ImmuneMed's 'hzVSF,' Used for Treatment of COVID-19 Pneumonia Patients
2020-03-30 21:00
Samsung Biologics expands leadership for CDO business
2020-03-30 21:00
WuXi Biologics Achieved Remarkable Results in 2019
2020-03-26 21:32
WuXi AppTec Reports Strong 2019 Annual Results
2020-03-24 18:56
Novogene unveils intelligent Next Generation Sequencing delivery platform - Falcon
2020-03-24 17:07
Samsung Biologics Adds Greater Expertise and Diversity to Its Board
2020-03-20 20:00
Glucagon Receptor Structures Reveal G protein Specificity Mechanism
2020-03-20 02:00
1
128
129
130
131
132
226